HI
GSK icon

Harbour Investments’s GSK GSK Stock Holding History

Harbour Investments’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$305K Buy
5,809
+18
+0.3% +$952 ﹤0.01% 1376
2026
Q1 		$320K Buy
5,791
+3,487
+151% +$189K ﹤0.01% 1274
2025
Q4 		$113K Sell
2,304
-583
-20% -$27.2K ﹤0.01% 1581
2025
Q3 		$125K Buy
2,887
+1,617
+127% +$63.2K ﹤0.01% 1479
2025
Q2 		$48.8K Sell
1,270
-1,320
-51% -$50.4K ﹤0.01% 1846
2025
Q1 		$100K Buy
2,590
+186
+8% +$6.81K ﹤0.01% 1438
2024
Q4 		$81.3K Buy
2,404
+63
+3% +$2.27K ﹤0.01% 1462
2024
Q3 		$95.7K Buy
2,341
+18
+0.8% +$736 ﹤0.01% 1344
2024
Q2 		$89.4K Buy
2,323
+303
+15% +$12.7K ﹤0.01% 1285
2024
Q1 		$86.6K Sell
2,020
-498
-20% -$20.5K ﹤0.01% 1278
2023
Q4 		$93.3K Buy
2,518
+672
+36% +$24.1K ﹤0.01% 1160
2023
Q3 		$66.9K Sell
1,846
-1,665
-47% -$59.1K ﹤0.01% 1217
2023
Q2 		$125K Sell
3,511
-31
-0.9% -$1.11K 0.01% 971
2023
Q1 		$126K Buy
3,542
+125
+4% +$4.37K 0.01% 946
2022
Q4 		$120K Buy
+3,417
New +$114K 0.01% 936
2021
Q4 		$134K Sell
2,425
-6,982
-74% -$363K 0.01% 854
2021
Q3 		$449K Sell
9,407
-2,896
-24% -$145K 0.01% 683
2021
Q2 		$612K Sell
12,303
-395
-3% -$19K 0.02% 599
2021
Q1 		$566K Buy
+12,698
New +$576K 0.02% 566

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Harbour Investments's GSK Position: Q2 2026 in Review

Harbour Investments increased its GSK (GSK) stake by 0.31% in Q2 2026, buying an estimated $952 and bringing the position to 5,809 shares worth $305K. The position accounts for ﹤0.01% of the portfolio, ranked #1376.

Harbour Investments first reported a position in GSK in Q1 2021 and has held it in 19 quarters since. The position peaked at $612K in Q2 2021. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Harbour Investments held 5,809 shares of GSK worth $305K as of Q2 2026.
  • Harbour Investments bought 18 GSK shares in Q2 2026, an estimated $952.
  • GSK made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1376 holding.
  • Harbour Investments first reported a position in GSK in Q1 2021 and has held it in 19 quarters since.
  • Harbour Investments's GSK position peaked at $612K in Q2 2021.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.